跳至主要内容
临床试验/NCT02110732
NCT02110732已完成不适用

Lactobacillus Rhamnosus GG in the Middle Ear and Adenoid Tonsil After Randomized, Double-blind, Placebo-controlled Oral Administration

Helsinki University Central Hospital0 个研究点目标入组 40 人开始时间: 2011年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
40
主要终点
Lactobacillus Rhamnosus GG in Middle Ear Effusion and Adenoid Tonsil

研究概览

简要总结

The purpose of this study is to evaluate the effect of oral administration of probiotic Lactobacillus rhamnosus GG in middle ear and adenoid tonsil.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
1 Year 至 5 Years(Child)
性别
All
接受健康志愿者

入选标准

  • recurrent otitis media
  • secretory otitis media
  • chronic rhinitis
  • recurrent sinusitis

排除标准

  • significant illness

结局指标

主要结局

Lactobacillus Rhamnosus GG in Middle Ear Effusion and Adenoid Tonsil

时间窗: After 3 weeks of oral consumption

Presence of Lactobacillus rhamnosus GG in middle ear effusion of children having tympanostomy after oral administration of L. GG.

次要结局

  • Presence of Bacterial Pathogens in Middle Ear Effusion Samples(After 3 weeks of oral consumption)
  • Presence of Rhinovirus and Enterovirus in Middle Ear Effusion Samples(After 3 weeks of oral consumption)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Anne pitkäranta

Professor/Chief Physician at Hospital District of Helsinki and Uusimaa

Helsinki University Central Hospital

相似试验

Lactobacillus Rhamnosus GG in the Middle Ear and... | 临床试验